Powered by EUROIMMUN
Neurodegeneration is charactized by progressive destruction of nerve cells in the central nervous system leading to e.g. disruption of memory, behaviour or motor skills.
Alzheimer’s disease is one of the most common forms of neurodegeneration and is the leading cause of dementia in older age. Amythrophic lateral sclerosis (ALS) is the most frequent motor neuron disease characterized by degeneration of motor neurons.
Our goal is to support the clinical diagnosis of neurodegenerative diseases at an early stage, so that patients can gain clarity about their symptoms and receive the best medical care.
With our automated IVD systems, laboratories benefit from complete solutions: we offer a sophisticated range of diagnostic assays for the assessment of measurable biomarkers, all of which can be proceeded with our innovative automation platforms.
Explore Our Clinical Solutions
We offer solutions for the measurement of the Alzheimer’s biomarkers beta-amyloid 1-42/1-40, phosphorylated tau and total tau. Also available: EUROArray APOE.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
Explore Our Research Solutions
We offer ELISA for measurement of Neurogranin, a postsynaptic protein and a promising presymptomatic biomarker of synaptic damage in the course of Alzheimer’s.
We offer ELISA for measurement of BACE1, a presynaptic protein and a possible biomarker of neurodegenerative processes in the course of Alzheimer’s.
For research use only. Not for use in diagnostic procedures.